Wednesday, June 17, 2009

Leerink Swann & Company Appoints Joshua Schimmer

Leerink Swann & Company announced that Joshua Schimmer, M.D. has joined the firm as managing director, biotechnology analyst. Dr. Schimmer will cover mid-and large-cap biotechnology companies for the Firm. Prior to joining Leerink Swann, Dr. Schimmer was a managing director for FTN Equity Capital Markets Corp. -Business Wire


Sector: Investment Banking |

Both comments and trackbacks are currently closed.